Robust Leptin Secretory Responses to Dexamethasone in Obese Subjects

Robust Leptin Secretory Responses to Dexamethasone in Obese Subjects,SAMUEL DAGOGO-JACK,GREGG SELKE,ANGELA K. MELSON,JOHN W. NEWCOMER

Robust Leptin Secretory Responses to Dexamethasone in Obese Subjects   (Citations: 35)
BibTex | RIS | RefWorks Download
Although leptin reverses obesity in rodents, its function and reg- ulation in humans are unknown. Glucocorticoids have been reported to stimulate leptin production in both rodents and humans, but data assessing the effect of obesity on dynamic leptin secretory responses are unavailable. We, therefore, studied 52 lean and obese subjects (20 men and 32 women; aged 19 - 84 yr; body mass index (BMI) range, 16 - 47 kg/m2) randomized to treatment with dexamethasone (total dose, 10 mg/4 days) or placebo. Compared with placebo, dexameth- asone increased (P 5 0.0001) plasma leptin levels by 64 -111% above baseline values within 2- 4 days. The increases occurred in all ages, showed no sexual dimorphism, and were particularly robust in obese subjects. After dexamethasone treatment, significant interactions were observed between the change in plasma leptin and BMI (P 5 0.0001), baseline plasma leptin (P 5 0.0006) and plasma dexameth- asone levels (P 5 0.04), but not age (P 5 0.28); an apparent interaction with plasma insulin no longer was significant after controlling for BMI. These results confirm dexamethasone-induced hyperleptinemia in humans and further demonstrate that the response is not defective in obesity. (J Clin Endocrinol Metab 82: 3230 -3233, 1997)
Published in 2010.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: